• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Another Gloomy Day for Amgen

    Another Gloomy Day for Amgen

  2. EUROPE MARKETS: European Stocks Finish Lower After Merkel Says Euro 'too Weak'

    EUROPE MARKETS: European Stocks Finish Lower After Merkel Says Euro 'too Weak'

  3. UPDATE: European stocks finish lower after Merkel says euro 'too weak'

    UPDATE: European stocks finish lower after Merkel says euro 'too weak'

  4. Harvard Pilgrim Signs Second Groundbreaking Contract with Amgen For Repatha

    Harvard Pilgrim Signs Second Groundbreaking Contract with Amgen For Repatha

  5. Amgen likely aiming to meet, not beat, first-quarter earnings expectations

    Amgen likely aiming to meet, not beat, first-quarter earnings expectations

  6. UPDATE: Amgen likely aiming to meet, not beat, first-quarter earnings expectations

    UPDATE: Amgen likely aiming to meet, not beat, first-quarter earnings expectations

  7. Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac

    Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac

  8. Global Neutropenia Treatment Market - Drivers and Forecasts by Technavio

    Global Neutropenia Treatment Market - Drivers and Forecasts by Technavio

  9. Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Pipeline Report, H1 2017 - Review of 14 Companies and Drug Profiles - Research and Markets

    Global Paroxysmal Nocturnal Hemoglobinuria Therapeutics Pipeline Report, H1 2017 - Review of 14 Companies and Drug Profiles - Research and Markets

  10. MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors

    MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors

12345

©2017 Morningstar Advisor. All right reserved.